Vivekananda Datta

2.5k total citations · 1 hit paper
21 papers, 1.5k citations indexed

About

Vivekananda Datta is a scholar working on Infectious Diseases, Cancer Research and Molecular Biology. According to data from OpenAlex, Vivekananda Datta has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 6 papers in Cancer Research and 5 papers in Molecular Biology. Recurrent topics in Vivekananda Datta's work include Antimicrobial Resistance in Staphylococcus (7 papers), Cancer Genomics and Diagnostics (6 papers) and Bacterial biofilms and quorum sensing (4 papers). Vivekananda Datta is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (7 papers), Cancer Genomics and Diagnostics (6 papers) and Bacterial biofilms and quorum sensing (4 papers). Vivekananda Datta collaborates with scholars based in United States, Canada and South Korea. Vivekananda Datta's co-authors include Bernard Beall, Victor Nizet, Darrin J. Bast, C. Kendall Stover, Jamese J. Hilliard, JoAnn Suzich, William W. Busse, Rohit Katial, Michel Laviolette and Néstor A. Molfino and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Vivekananda Datta

18 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia

2013 370 citations Michel Laviolette, David Gossage et al. Journal of Allergy and Clinical Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vivekananda Datta United States	15	530	395	380	350	269	21	1.5k
Helen L. Leavis Netherlands	22	1.1k 2.1×	298 0.8×	118 0.3×	759 2.2×	126 0.5×	69	2.2k
Jean‐San Chia Taiwan	29	221 0.4×	436 1.1×	130 0.3×	481 1.4×	129 0.5×	75	1.9k
Shu Okugawa Japan	19	416 0.8×	99 0.3×	144 0.4×	490 1.4×	87 0.3×	88	1.5k
David Ermert Sweden	18	511 1.0×	218 0.6×	191 0.5×	564 1.6×	233 0.9×	27	2.2k
Bret R. Sellman United States	21	655 1.2×	159 0.4×	89 0.2×	501 1.4×	69 0.3×	35	1.2k
Bas G. J. Surewaard Canada	22	781 1.5×	159 0.4×	103 0.3×	925 2.6×	142 0.5×	32	2.4k
Rebecca T. Horvat United States	21	416 0.8×	85 0.2×	99 0.3×	434 1.2×	93 0.3×	53	1.6k
Per Åkesson Sweden	24	674 1.3×	972 2.5×	70 0.2×	345 1.0×	140 0.5×	47	2.2k
H M Jansen Netherlands	31	290 0.5×	91 0.2×	549 1.4×	311 0.9×	696 2.6×	69	2.2k
Bernard Ryffel France	21	311 0.6×	216 0.5×	93 0.2×	503 1.4×	200 0.7×	23	1.9k

Countries citing papers authored by Vivekananda Datta

Since Specialization

Citations

This map shows the geographic impact of Vivekananda Datta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vivekananda Datta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vivekananda Datta more than expected).

Fields of papers citing papers by Vivekananda Datta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vivekananda Datta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vivekananda Datta. The network helps show where Vivekananda Datta may publish in the future.

Co-authorship network of co-authors of Vivekananda Datta

This figure shows the co-authorship network connecting the top 25 collaborators of Vivekananda Datta. A scholar is included among the top collaborators of Vivekananda Datta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vivekananda Datta. Vivekananda Datta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Batish, Sat Dev, et al.. (2021). HTT CAG Repeat Length Variation in Huntington Disease (HD) Patients: Experience from a US Reference Laboratory (2376). Neurology. 96(15_supplement). 1 indexed citations

Batish, Sat Dev, et al.. (2021). Cerebrospinal fluid AΒ₄₂, total tau, and phosphorylated tau in the evaluation of Alzheimer’s dementia: Experience from a commercial reference laboratory. Alzheimer s & Dementia. 17(S5).

Kummar, Shivaani, Nicole M. Moore, Larry Rubinstein, et al.. (2019). Genomic profiling of three pathways through molecular profiling-based assignment of cancer therapy (NCI- MPACT). Annals of Oncology. 30. v164–v165. 1 indexed citations

Ferry‐Galow, Katherine V., Vivekananda Datta, Hala R. Makhlouf, et al.. (2018). What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?. Journal of Oncology Practice. 14(11). e722–e728. 32 indexed citations

Sissung, Tristan M., Juan J.L. Lertora, Parag Kumar, et al.. (2017). Pharmacogenomics Implementation at the National Institutes of Health Clinical Center. The Journal of Clinical Pharmacology. 57(S10). S67–S77. 16 indexed citations

Kalman, Lisa V., Vivekananda Datta, Mickey Williams, et al.. (2016). Development and Characterization of Reference Materials for Genetic Testing: Focus on Public Partnerships. Annals of Laboratory Medicine. 36(6). 513–520. 15 indexed citations

Le, Vien T. M., Christine Tkaczyk, Lily Cheng, et al.. (2016). Critical Role of Alpha-Toxin and Protective Effects of Its Neutralization by a Human Antibody in Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 60(10). 5640–5648. 35 indexed citations

Chen, Alice P., Mickey Williams, Shivaani Kummar, et al.. (2016). Feasibility of molecular profiling based assignment of cancer treatment (MPACT): A randomized NCI precision medicine study.. Journal of Clinical Oncology. 34(15_suppl). 2539–2539. 4 indexed citations

Lih, Chih-Jian, David Sims, Eric C. Polley, et al.. (2015). Analytical Validation and Application of a Targeted Next-Generation Sequencing Mutation-Detection Assay for Use in Treatment Assignment in the NCI-MPACT Trial. Journal of Molecular Diagnostics. 18(1). 51–67. 29 indexed citations

10.

Doroshow, James H., Melinda G. Hollingshead, Yvonne A. Evrard, et al.. (2015). Abstract PL08-02: NCI patient derived models repository. Molecular Cancer Therapeutics. 14(12_Supplement_2). PL08–2.

11.

Long, Hua, Taylor S. Cohen, Yuru Shi, et al.. (2015). MEDI4893* Promotes Survival and Extends the Antibiotic Treatment Window in a Staphylococcus aureus Immunocompromised Pneumonia Model. Antimicrobial Agents and Chemotherapy. 59(8). 4526–4532. 55 indexed citations

12.

DiGiandomenico, Antonio, Ashley Keller, Cuihua Gao, et al.. (2014). A multifunctional bispecific antibody protects against Pseudomonas aeruginosa. Science Translational Medicine. 6(262). 262ra155–262ra155. 215 indexed citations

13.

Hilliard, Jamese J., Vivekananda Datta, Christine Tkaczyk, et al.. (2014). Anti-Alpha-Toxin Monoclonal Antibody and Antibiotic Combination Therapy Improves Disease Outcome and Accelerates Healing in a Staphylococcus aureus Dermonecrosis Model. Antimicrobial Agents and Chemotherapy. 59(1). 299–309. 45 indexed citations

14.

Tkaczyk, Christine, Melissa Hamilton, Vivekananda Datta, et al.. (2013). Staphylococcus aureus Alpha Toxin Suppresses Effective Innate and Adaptive Immune Responses in a Murine Dermonecrosis Model. PLoS ONE. 8(10). e75103–e75103. 69 indexed citations

15.

Laviolette, Michel, David Gossage, Gail M. Gauvreau, et al.. (2013). Effects of benralizumab on airway eosinophils in asthmatic patients with sputum eosinophilia. Journal of Allergy and Clinical Immunology. 132(5). 1086–1096.e5. 370 indexed citations breakdown →

16.

Long, Hua, Jamese J. Hilliard, Yuru Shi, et al.. (2013). Assessment of an Anti-Alpha-Toxin Monoclonal Antibody for Prevention and Treatment of Staphylococcus aureus-Induced Pneumonia. Antimicrobial Agents and Chemotherapy. 58(2). 1108–1117. 138 indexed citations

17.

Kansal, Rina, et al.. (2012). Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis. Genes Chromosomes and Cancer. 52(1). 99–106. 44 indexed citations

18.

Jeng, Arthur, Varja Sakota, Zhongya Li, et al.. (2003). Molecular Genetic Analysis of a Group AStreptococcusOperon Encoding Serum Opacity Factor and a Novel Fibronectin-Binding Protein, SfbX. Journal of Bacteriology. 185(4). 1208–1217. 133 indexed citations

19.

Datta, Vivekananda, et al.. (2002). Streptolysin S and necrotising infections produced by group G streptococcus. The Lancet. 359(9301). 124–129. 113 indexed citations

20.

Datta, Vivekananda. (1985). Academic status for university and college librarians in India. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact